Cite
HARVARD Citation
Ge, W. et al. (2020). High‐risk Stage III colon cancer patients identified by a novel five‐gene mutational signature are characterized by upregulation of IL‐23A and gut bacterial translocation of the tumor microenvironment. International journal of cancer. 146 (7), pp. 2027-2035. [Online].